Details for New Drug Application (NDA): 070770
✉ Email this page to a colleague
NDA 070770 describes DISOBROM, which is a drug marketed by Sandoz and is included in one NDA. Additional details are available on the DISOBROM profile page.
The generic ingredient in DISOBROM is dexbrompheniramine maleate; pseudoephedrine sulfate. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dexbrompheniramine maleate; pseudoephedrine sulfate profile page.
The generic ingredient in DISOBROM is dexbrompheniramine maleate; pseudoephedrine sulfate. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dexbrompheniramine maleate; pseudoephedrine sulfate profile page.
Summary for 070770
| Tradename: | DISOBROM |
| Applicant: | Sandoz |
| Ingredient: | dexbrompheniramine maleate; pseudoephedrine sulfate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 6MG;120MG | ||||
| Approval Date: | Sep 30, 1991 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
